Autologous Hematopoietic Stem Cell Transplantation

Pipeline Programs↗

Active Trials↗

Companies Involved↗

Autologous Hematopoietic Stem Cell Transplantation is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

71/100

Attrition Rate

14/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

clinical trials

Completed5 · 36%

Recruiting3 · 21%

Unknown status2 · 14%

Terminated1 · 7%

Active, not recruiting1 · 7%

Withdrawn1 · 7%

Other1 · 7%

Clinical Trials

Trial Activity

14 trials

Orelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL Treatment

Recruiting·RRuijin Hospital·Phase 2·NCT07199296·45 enrolled

G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation

Recruiting·FFudan University·Phase 2·NCT07362810·224 enrolled

Mozobil for Autologous Hematopoietic Stem Cell Transplantation

Recruiting·TThomas Jefferson University·Phase 2·NCT07188090·100 enrolled

Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS)

Active, not recruiting·HHaukeland University Hospital·Phase 3·NCT03477500·100 enrolled

CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation

Not yet recruiting·ZZhengzhou University·Phase 1/2·NCT07117305·38 enrolled

Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

Completed·SSamsung Medical Center·Phase 4·NCT00336531·100 enrolled

Generic Plerixafor Efficacy of Autologous Hematopoietic Stem Cell Transplantation

Completed·HHospital Universitario Dr. Jose E. Gonzalez·Phase 1·NCT06892119·6 enrolled

Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance

Completed·GGary A Levy, O. Ont. MD. FRCP AGAF·Phase 2·NCT02549586·5 enrolled

Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation

Completed·UUniversity of Alabama at Birmingham·Phase 1/2·NCT01690143·45 enrolled

Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)

Completed·UUniversity of Liege·Phase 2/3·NCT00557817·125 enrolled

Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)

Terminated·MM.D. Anderson Cancer Center·N/A·NCT01927718·10 enrolled

Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment

Withdrawn·UUniversity of California, Los Angeles·Phase 1·NCT01932658

Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation

Unknown status·SSeoul National University Hospital·Phase 2·NCT01417169·112 enrolled

A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation

Unknown status·—·Phase 4·NCT02576327·130 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)